ustekinumab
Form | Strength |
---|---|
SOLUTION, SUBCUTANEOUS | 45 mg/0.5 mL; 90 mg/mL |
Per policy, use of these medications is restricted as noted below: | |
---|---|
generic (Brand) | Restrictions |
ustekinumab (Stelara) | Restricted from being administered at IMH, including ICS. |